Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events

Cardiovascular Drugs and Therapy

Volumn 10, Issue 5, 1996, Pages 549-556

  Brembilla Perrot, Béatrice ^a   Jacquemin, Laurent ^a   De La Chaise, Arnaud Terrier ^a   Beurrier, Daniel ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Antiarrhythmic drug; Myocardial infarction; Programmed ventricular stimulation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; QUINIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; TECHNIQUE;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK;

EID: 0029857020     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00050995     Document Type: Article

References (27)

1. Breithardt G, Borggrefe M, Haerten K. Ventricular late potentials and inducible ventricular tachyarrhythmias as a marker for ventricular tachycardia after myocardial infarction. Eur Heart J 1986;7(Suppl A):127-134.
2. Denniss AR, Richard DA, Cody DV, et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 1986;74:737-745.
3. Bourke JP, Richard DA, Ross DL, Wallace EM, McGuire MA, Uther JB. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol 1992;18:780-788.
4. Brembilla-Perrot B, Terrier de la Chaise A, Briançon A, et al. Programmed ventricular stimulation in survivors of acute myocardial infarction: Long-term follow-up. Int J Cardiol 1995;49:55-65.
5. Brembilla-Perrot B, Donetti J, Terrier de la Chaise A, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124-1131.
6. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH and the CAST investigators. CAST mortality and morbidity. Treatment versus placebo. N Engl J Med 1991;324:781-788.
7. Leclercq JF, Leenhardt A, Lemarec H, Clementy J, Hermida JS, Sebag C, Aliot E. Predictive value of electrophysiologic studies during treatment of ventricular tachycardia with the beta-blocking agent nadolol J Am Coll Cardiol 1990;16:413-417.
8. Waller TH, Kay HR, Spielman SR, Kutalek SP, Greenspan AM, Horowitz LW. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachycardia J Am Coll Cardiol 1987; 10:83-89.
9. Kuchar DL, Garan H, Ruskin JN. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmia. Am J Coll Cardiol 1988;62:39H-45H.
10. Kadish A, Buxton AE, Waxman HL, Flores M, Josephson ME, Marchlinski FE. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. J Am Coll Cardiol 1987;10:90-96.
11. Poser RF, Podrid PJ, Lombardi F, Lown B. Aggravation of arrhythmia induced with antiarrhythmic drug during electrophysiologic testing. Am Heart J 1985;110:9-16.
12. Kuchar DL, Rottman J, Berger E, Freedman CS, Garan H, Ruskin JN. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. J Am Coll Cardiol 1988;12:982-988.
13. Spielman SR, Schwartz JS, McCarthy DM, et al. Prediction of response to class I antiarrhythmic drugs during electro-physiologic study of ventricular tachycardia. J Am Coll Cardiol 1983;1:401-416.
14. Swiryn S, Bauernfeind RA, Stsasberg B, Palileo E, Iverson N, Levy PS, Rosen KM. Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia. Am Heart J 1982;104:43-50.
15. Brembilla-Perrot B, Terrier de la Chaise A, Skeik L, Cherrier F, Pernot C. Facteurs prédictifs de réponse à un antiarythmique au cours d'une étude électrophysiologique pour tachycardie ventriculaire. Arch Mal Coeur 1987;10:1497-503.
16. Schoenfeld MH, McGovern B, Geran H. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias. J Am Coll Cardiol 1985;6: 298-306.
17. Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 1983;52: 32C-36C.
18. Gottlieb SH, Achuff SC, Mellits DE, et al. Prophylactic antiarrhythmic therapy of righ-risk survivors of myocardial infarction: Lower mortality at 1 month but not at 1 year. Circulation 1987;75:792-799.
19. Hine LK, Laird N, Ewitt P, Chalmers TC. Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. JAMA 1989;262:3037-3040.
20. Greene HL, Roden DM, Katz RJ, Woosley RL, Salerno DM, Henthorn RW and the CAST investigators. The Cardiac Arrhythmia Suppression Trial: First CAST. . . Then CAST-II. J Am Coll Cardiol 1992;19:894-889.
21. Kostis JB, Byington R, Friedman LM, Goldstein S, Furberg C for the BHAT Study Group. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol 1987;10:231-242.
22. Kanosky MS, Falcone RA, Dresden CA, Josephson ME, Simson MB. Identification of patients with ventricular tachycardia after myocardial infarction. Signal-averaged electrocardiogram Holter monitoring and cardiac catheterization. Circulation 1984;70:264-270.
23. Middlekauff HR, Stevenson WG, Tillisch JH. Prevention of sudden death in survivors of myocardial infarction: A decision analysis approach. Am Heart J 1992;123:475-480.
24. Denniss AR, Ross DL, Cody DV, Russell PA, Young AA, Richards A, Uther JB. Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction. Eur Heart J 1988;9:746-757.
25. Bourke JP, Richards DAB, Ross DL, McGuire MA, Uther JB. Prediction of arrhythmic events on the first year following myocardial infarction by electrophysiologic testing: Definition of a negative result. (abstr). J Am Coll Cardiol 1992;19:283.
26. Aronow WS, Mercando AD, Epstein S, Kronzon I. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death and total death in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1990;66:423-428.
27. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basal anti-arrhythmic study of infarct survival (BASIS). J Am Coll Cardiol 1990;16: 1711-1718.